Delivery Order SPE2DE21D7010-SPE2D626F34V2
- Not listed
- This delivery order, valued at $28,797.06, was awarded on November 26, 2025, to Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in advanced spinal surgery products and services for federal healthcare agencies. The award is a fixed-price contract with economic price adjustment provisions, issued by the Defense Logistics Agency (DLA) Medical Supply Chain for the MODULUS product line. The contract has no set-aside designation and represents an open market competitive...
- This delivery order, valued at $15,421.95, was awarded on November 25, 2025, to Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in advanced spinal surgery products and services for federal healthcare agencies. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a $11,287.94 fixed-price delivery order (Contract 4569593362) by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The delivery order, which includes economic price adjustment provisions, is designated for the MODULUS product line and has an ultimate completion date of September 23, 2025. The contract was awarded without set-aside...
- This delivery order, valued at $19,373.40, was awarded to Nuvasive, Inc. on July 21, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract utilizes a fixed-price structure with economic price adjustment provisions and will be performed in San Diego, California, with completion targeted for August 12, 2025. The award is associated with the MODULUS product line and was made without a set-aside designation, indicating open competition....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order contract valued at $7,358.52 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, with a completion date of October 24, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the supply of the MODULUS spinal surgical product to support federal healthcare operations. This award...
- This delivery order, awarded November 6, 2025, represents a $3,227.70 fixed-price contract with economic price adjustment provisions issued by the Defense Logistics Agency Medical Supply Chain to Nuvasive, Inc. for the delivery of MODULUS spinal surgical products. The contract will be performed at Nuvasive's San Diego, California facility with an ultimate completion date of November 7, 2025, reflecting the urgent medical supply requirements of the Defense Health System. This is a non-set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,477.02 on December 4, 2025, for the MODULUS spinal surgical product through the Defense Logistics Agency (DLA) Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 31, 2025, with performance occurring at Nuvasive's San Diego facility. The award carries no set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, has been awarded a delivery order valued at $22,408.89 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The contract, which carries no set-aside designation, is for the delivery of MODULUS spinal medical products and is structured as a fixed-price agreement with economic price adjustment provisions. Performance is scheduled to conclude by October...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The contract, designated as Delivery Order 4570101607, involves the procurement of MODULUS spinal surgical products and is structured as a fixed-price agreement with economic price adjustment provisions to accommodate cost fluctuations in specialized medical device...
- On September 15, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $12,969.81 to Nuvasive, Inc. for the provision of MODULUS spinal medical devices. The contract, which carries no set-aside designation, represents a fixed-price delivery order with economic price adjustment pricing mechanisms and is scheduled for completion by October 3, 2025. Performance will take place at Nuvasive's facility in San Diego, California. This delivery order...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F34V2Delivery Order
This delivery order, valued at $11,287.94, was awarded to Nuvasive, Inc. on December 4, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for the provision of MODULUS spinal surgical products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of January 8, 2026. Performance will be conducted at Nuvasive's facility in San Diego, California. This award was issued without set-aside restrictions, indicating successful competition in the open market procurement process. Nuvasive, Inc. operates as a San Diego-based subsidiary of Transplant Technology Inc.'s Bone Bank Allografts Division and serves as a critical supplier of advanced spinal surgery products and services to federal healthcare agencies, particularly the Department of Defense, Department of Veterans Affairs, and Defense Health Agency. This delivery order is issued under the broader $8 million Blanket Purchase Agreement (IDIQ) vehicle maintained between Transplant Technology Inc. and the Defense Health Agency, effective through March 2027, which streamlines procurement of Nuvasive's comprehensive spinal fusion devices, implants, surgical instruments, and bone graft materials across military and veteran healthcare facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 12/3/25 |